Sketching the contours of state authenticity

We outline a program of research in which we examined state authenticity, the sense of being one’s true self. In particular, we describe its phenomenology (what it feels like to be experience authenticity), its correlates(e.g.,emotions,needs),itsnomologicalnetwork(e.g.,real-idealselfoverlap,publicandprivate self-consciousness), its cultural parameters (Easter and Western culture), its precursors or determinants (congruency, positivity, and hedonism), and its psychological health implications. We conclude by arguing that state authenticity deserves its own conceptual status, distinct from trait authenticity, and by setting an agenda for future research

Identifying differences in the experience of (in)authenticity: a latent class analysis approach

Generally, psychologists consider state authenticity– that is, the subjective sense of being one’s true self – to be a unitary and unidimensional construct, such that (a) the phenomenological experience of authenticity is thought to be similar no matter its trigger, and (b) inauthenticity is thought to be simply the opposing pole (on the same underlying construct) of authenticity. Using latent class analysis, we put this conceptualization to a test. In order to avoid over-reliance on a Western conceptualization of authenticity, we used a cross-cultural sample (N = 543), comprising participants from Western, South-Asian, East-Asian, and South-East Asian cultures. Participants provided either a narrative in which the described when they felt most like being themselves or one in which they described when they felt least like being themselves. The analysis identified six distinct classes of experiences: two authenticity classes ('everyday' and 'extraordinary'), three inauthenticity classes ('self-conscious,' 'deflated,' and 'extraordinary'), and a class representing convergence between authenticity and inauthenticity. The classes were phenomenologically distinct, especially with respect to negative affect, private and public self-consciousness, and self-esteem. Furthermore, relatively more interdependent cultures were less likely to report experiences of extraordinary (in)authenticity than relatively more independent cultures. Understanding the many facets of (in)authenticity may enable researchers to connect different findings and explain why the attainment of authenticity can be difficult

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

Background Previous evidence indicates that adjuvant, short-course androgen deprivation therapy (ADT) improves metastasis-free survival when given with primary radiotherapy for intermediate-risk and high-risk localised prostate cancer. However, the value of ADT with postoperative radiotherapy after radical prostatectomy is unclear. Methods RADICALS-HD was an international randomised controlled trial to test the efficacy of ADT used in combination with postoperative radiotherapy for prostate cancer. Key eligibility criteria were indication for radiotherapy after radical prostatectomy for prostate cancer, prostate-specific antigen less than 5 ng/mL, absence of metastatic disease, and written consent. Participants were randomly assigned (1:1) to radiotherapy alone (no ADT) or radiotherapy with 6 months of ADT (short-course ADT), using monthly subcutaneous gonadotropin-releasing hormone analogue injections, daily oral bicalutamide monotherapy 150 mg, or monthly subcutaneous degarelix. Randomisation was done centrally through minimisation with a random element, stratified by Gleason score, positive margins, radiotherapy timing, planned radiotherapy schedule, and planned type of ADT, in a computerised system. The allocated treatment was not masked. The primary outcome measure was metastasis-free survival, defined as distant metastasis arising from prostate cancer or death from any cause. Standard survival analysis methods were used, accounting for randomisation stratification factors. The trial had 80% power with two-sided α of 5% to detect an absolute increase in 10-year metastasis-free survival from 80% to 86% (hazard ratio [HR] 0·67). Analyses followed the intention-to-treat principle. The trial is registered with the ISRCTN registry, ISRCTN40814031, and ClinicalTrials.gov, NCT00541047. Findings Between Nov 22, 2007, and June 29, 2015, 1480 patients (median age 66 years [IQR 61–69]) were randomly assigned to receive no ADT (n=737) or short-course ADT (n=743) in addition to postoperative radiotherapy at 121 centres in Canada, Denmark, Ireland, and the UK. With a median follow-up of 9·0 years (IQR 7·1–10·1), metastasis-free survival events were reported for 268 participants (142 in the no ADT group and 126 in the short-course ADT group; HR 0·886 [95% CI 0·688–1·140], p=0·35). 10-year metastasis-free survival was 79·2% (95% CI 75·4–82·5) in the no ADT group and 80·4% (76·6–83·6) in the short-course ADT group. Toxicity of grade 3 or higher was reported for 121 (17%) of 737 participants in the no ADT group and 100 (14%) of 743 in the short-course ADT group (p=0·15), with no treatment-related deaths. Interpretation Metastatic disease is uncommon following postoperative bed radiotherapy after radical prostatectomy. Adding 6 months of ADT to this radiotherapy did not improve metastasis-free survival compared with no ADT. These findings do not support the use of short-course ADT with postoperative radiotherapy in this patient population

Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial

Background Previous evidence supports androgen deprivation therapy (ADT) with primary radiotherapy as initial treatment for intermediate-risk and high-risk localised prostate cancer. However, the use and optimal duration of ADT with postoperative radiotherapy after radical prostatectomy remains uncertain. Methods RADICALS-HD was a randomised controlled trial of ADT duration within the RADICALS protocol. Here, we report on the comparison of short-course versus long-course ADT. Key eligibility criteria were indication for radiotherapy after previous radical prostatectomy for prostate cancer, prostate-specific antigen less than 5 ng/mL, absence of metastatic disease, and written consent. Participants were randomly assigned (1:1) to add 6 months of ADT (short-course ADT) or 24 months of ADT (long-course ADT) to radiotherapy, using subcutaneous gonadotrophin-releasing hormone analogue (monthly in the short-course ADT group and 3-monthly in the long-course ADT group), daily oral bicalutamide monotherapy 150 mg, or monthly subcutaneous degarelix. Randomisation was done centrally through minimisation with a random element, stratified by Gleason score, positive margins, radiotherapy timing, planned radiotherapy schedule, and planned type of ADT, in a computerised system. The allocated treatment was not masked. The primary outcome measure was metastasis-free survival, defined as metastasis arising from prostate cancer or death from any cause. The comparison had more than 80% power with two-sided α of 5% to detect an absolute increase in 10-year metastasis-free survival from 75% to 81% (hazard ratio [HR] 0·72). Standard time-to-event analyses were used. Analyses followed intention-to-treat principle. The trial is registered with the ISRCTN registry, ISRCTN40814031, and ClinicalTrials.gov , NCT00541047 . Findings Between Jan 30, 2008, and July 7, 2015, 1523 patients (median age 65 years, IQR 60–69) were randomly assigned to receive short-course ADT (n=761) or long-course ADT (n=762) in addition to postoperative radiotherapy at 138 centres in Canada, Denmark, Ireland, and the UK. With a median follow-up of 8·9 years (7·0–10·0), 313 metastasis-free survival events were reported overall (174 in the short-course ADT group and 139 in the long-course ADT group; HR 0·773 [95% CI 0·612–0·975]; p=0·029). 10-year metastasis-free survival was 71·9% (95% CI 67·6–75·7) in the short-course ADT group and 78·1% (74·2–81·5) in the long-course ADT group. Toxicity of grade 3 or higher was reported for 105 (14%) of 753 participants in the short-course ADT group and 142 (19%) of 757 participants in the long-course ADT group (p=0·025), with no treatment-related deaths. Interpretation Compared with adding 6 months of ADT, adding 24 months of ADT improved metastasis-free survival in people receiving postoperative radiotherapy. For individuals who can accept the additional duration of adverse effects, long-course ADT should be offered with postoperative radiotherapy. Funding Cancer Research UK, UK Research and Innovation (formerly Medical Research Council), and Canadian Cancer Society

A meta-analysis on the malleability of automatic gender stereotypes

This meta-analytic review examined the efficacy of interventions aimed at reducing automatic gender stereotypes. Such interventions included attentional distraction, salience of within-category heterogeneity, and stereotype suppression. A small but significant main effect (g?=?.32) suggests that these interventions are successful but that their scope is limited. The intervention main effect was moderated by publication status, sample nationality, and intervention type. The meta-analytic findings suggest several issues worthy of further investigation, such as whether (a) other categories of intervention not yet identified or tested could be more effective, (b) suppression necessarily produces ironic effects in automatic stereotyping, (c) various indirect measures are differentially sensitive to stereotype change, and (d) automatic stereotypes about men differ in their malleability from those about women.<br/

Changing her ways

Researchers know very little about extit{how} people choose mates. To remedy this, the present study examined the influence of number of potential mates and mate-standard strength on single women's choice satisfaction and strategy use. Single women chose one potential partner from a set of 4, 24, or 64 options presented on a real dating website. Participants adjusted to an increasing number of options by changing their decision-making strategies, such that they relied on noncompensatory, attribute-based strategies as the number of options increased. Across conditions they reported similar levels of satisfaction with the choice process and the person selected. Mate-standard strength qualified some of the results, however, as women with higher mate standards preferred extensive choice, and they tended to prefer compensatory choice strategies and were more satisfied with the option selected when he was selected from among many

Changing her ways: The number of options and mate-standard strength impact mate choice strategy and satisfaction

Researchers know very little about \textit{how} people choose mates. To remedy this, the present study examined the influence of number of potential mates and mate-standard strength on single women's choice satisfaction and strategy use. Single women chose one potential partner from a set of 4, 24, or 64 options presented on a real dating website. Participants adjusted to an increasing number of options by changing their decision-making strategies, such that they relied on noncompensatory, attribute-based strategies as the number of options increased. Across conditions they reported similar levels of satisfaction with the choice process and the person selected. Mate-standard strength qualified some of the results, however, as women with higher mate standards preferred extensive choice, and they tended to prefer compensatory choice strategies and were more satisfied with the option selected when he was selected from among many.mate choice; choice strategies; heuristics; choice satisfaction; standards.